View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In episode 17 of this series, Arthur Kim, MD, provides a brief update on the latest COVID-19 treatment options and guidelines. After the update, Dr. Kim answers questions submitted by healthcare professionals on various aspects of COVID-19.
Presenter:
Arthur Kim, MD
Associate Professor
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts
Contact Clinical Care Options
For customer support please email: customersupport@clinicaloptions.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Clinical Care Options’ (CCO) commentary from Dr. Sharon Lewin on new data on monoclonal antibodies for COVID-19 prevention and treatment
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: July 7, 2021
Clinical Care Options’ (CCO) commentary from Dr. Gregory Olson and colleagues on COVID-19 vaccination in immunocompromised patients
Christopher J. Lehmann, MD
Gregory Olson, MD
Renslow Sherer, MD
Released: June 28, 2021
Clinical Care Options’ (CCO) expert commentary from Dr. Renslow Sherer and colleagues on the risk of severe COVID-19 in patients with HIV and/or other forms of immunocompromise
Christopher J. Lehmann, MD
Gregory Olson, MD
Renslow Sherer, MD
Released: June 10, 2021
Clinical Care Options’ (CCO) commentary from a person with HIV on what it was like living through the COVID-19 pandemic as a long-term HIV survivor
Frank Primavera
Released: June 9, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.